OTC Drug-South America Market Status and Trend Report 2013-2023
Report Summary
OTC Drug-South America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on OTC Drug industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole South America and Regional Market Size of OTC Drug 2013-2017, and development forecast 2018-2023
Main market players of OTC Drug in South America, with company and product introduction, position in the OTC Drug market
Market status and development trend of OTC Drug by types and applications
Cost and profit status of OTC Drug, and marketing status
Market growth drivers and challenges
The report segments the South America OTC Drug market as:
South America OTC Drug Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Brazil
Argentina
Venezuela
Colombia
Others
South America OTC Drug Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Class A
Class B
South America OTC Drug Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Clinic
Household
South America OTC Drug Market: Players Segment Analysis (Company and Product introduction, OTC Drug Sales Volume, Revenue, Price and Gross Margin):
Bayer HealthCare
GlaxoSmithKline (GSK)
Johnson&Johnson
Pfizer
Sanofi
AstraZeneca
BioGaia
Bristol Myers Squibb
Bukwang Pharmaceutica
Chr. Hansen
Cipla
CoLucid
Daiichi Sankyo
Friggs
DSM
Eisai
Eli Lilly
Herbalife
Euradite
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
OTC Drug-South America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on OTC Drug industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole South America and Regional Market Size of OTC Drug 2013-2017, and development forecast 2018-2023
Main market players of OTC Drug in South America, with company and product introduction, position in the OTC Drug market
Market status and development trend of OTC Drug by types and applications
Cost and profit status of OTC Drug, and marketing status
Market growth drivers and challenges
The report segments the South America OTC Drug market as:
South America OTC Drug Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Brazil
Argentina
Venezuela
Colombia
Others
South America OTC Drug Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Class A
Class B
South America OTC Drug Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Clinic
Household
South America OTC Drug Market: Players Segment Analysis (Company and Product introduction, OTC Drug Sales Volume, Revenue, Price and Gross Margin):
Bayer HealthCare
GlaxoSmithKline (GSK)
Johnson&Johnson
Pfizer
Sanofi
AstraZeneca
BioGaia
Bristol Myers Squibb
Bukwang Pharmaceutica
Chr. Hansen
Cipla
CoLucid
Daiichi Sankyo
Friggs
DSM
Eisai
Eli Lilly
Herbalife
Euradite
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF OTC DRUG
1.1 Definition of OTC Drug in This Report
1.2 Commercial Types of OTC Drug
1.2.1 Class A
1.2.2 Class B
1.3 Downstream Application of OTC Drug
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Household
1.4 Development History of OTC Drug
1.5 Market Status and Trend of OTC Drug 2013-2023
1.5.1 South America OTC Drug Market Status and Trend 2013-2023
1.5.2 Regional OTC Drug Market Status and Trend 2013-2023
CHAPTER 2 SOUTH AMERICA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of OTC Drug in South America 2013-2017
2.2 Consumption Market of OTC Drug in South America by Regions
2.2.1 Consumption Volume of OTC Drug in South America by Regions
2.2.2 Revenue of OTC Drug in South America by Regions
2.3 Market Analysis of OTC Drug in South America by Regions
2.3.1 Market Analysis of OTC Drug in Brazil 2013-2017
2.3.2 Market Analysis of OTC Drug in Argentina 2013-2017
2.3.3 Market Analysis of OTC Drug in Venezuela 2013-2017
2.3.4 Market Analysis of OTC Drug in Colombia 2013-2017
2.3.5 Market Analysis of OTC Drug in Others 2013-2017
2.4 Market Development Forecast of OTC Drug in South America 2018-2023
2.4.1 Market Development Forecast of OTC Drug in South America 2018-2023
2.4.2 Market Development Forecast of OTC Drug by Regions 2018-2023
CHAPTER 3 SOUTH AMERICA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole South America Market Status by Types
3.1.1 Consumption Volume of OTC Drug in South America by Types
3.1.2 Revenue of OTC Drug in South America by Types
3.2 South America Market Status by Types in Major Countries
3.2.1 Market Status by Types in Brazil
3.2.2 Market Status by Types in Argentina
3.2.3 Market Status by Types in Venezuela
3.2.4 Market Status by Types in Colombia
3.2.5 Market Status by Types in Others
3.3 Market Forecast of OTC Drug in South America by Types
CHAPTER 4 SOUTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of OTC Drug in South America by Downstream Industry
4.2 Demand Volume of OTC Drug by Downstream Industry in Major Countries
4.2.1 Demand Volume of OTC Drug by Downstream Industry in Brazil
4.2.2 Demand Volume of OTC Drug by Downstream Industry in Argentina
4.2.3 Demand Volume of OTC Drug by Downstream Industry in Venezuela
4.2.4 Demand Volume of OTC Drug by Downstream Industry in Colombia
4.2.5 Demand Volume of OTC Drug by Downstream Industry in Others
4.3 Market Forecast of OTC Drug in South America by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF OTC DRUG
5.1 South America Economy Situation and Trend Overview
5.2 OTC Drug Downstream Industry Situation and Trend Overview
CHAPTER 6 OTC DRUG MARKET COMPETITION STATUS BY MAJOR PLAYERS IN SOUTH AMERICA
6.1 Sales Volume of OTC Drug in South America by Major Players
6.2 Revenue of OTC Drug in South America by Major Players
6.3 Basic Information of OTC Drug by Major Players
6.3.1 Headquarters Location and Established Time of OTC Drug Major Players
6.3.2 Employees and Revenue Level of OTC Drug Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 OTC DRUG MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Bayer HealthCare
7.1.1 Company profile
7.1.2 Representative OTC Drug Product
7.1.3 OTC Drug Sales, Revenue, Price and Gross Margin of Bayer HealthCare
7.2 GlaxoSmithKline (GSK)
7.2.1 Company profile
7.2.2 Representative OTC Drug Product
7.2.3 OTC Drug Sales, Revenue, Price and Gross Margin of GlaxoSmithKline (GSK)
7.3 Johnson&Johnson
7.3.1 Company profile
7.3.2 Representative OTC Drug Product
7.3.3 OTC Drug Sales, Revenue, Price and Gross Margin of Johnson&Johnson
7.4 Pfizer
7.4.1 Company profile
7.4.2 Representative OTC Drug Product
7.4.3 OTC Drug Sales, Revenue, Price and Gross Margin of Pfizer
7.5 Sanofi
7.5.1 Company profile
7.5.2 Representative OTC Drug Product
7.5.3 OTC Drug Sales, Revenue, Price and Gross Margin of Sanofi
7.6 AstraZeneca
7.6.1 Company profile
7.6.2 Representative OTC Drug Product
7.6.3 OTC Drug Sales, Revenue, Price and Gross Margin of AstraZeneca
7.7 BioGaia
7.7.1 Company profile
7.7.2 Representative OTC Drug Product
7.7.3 OTC Drug Sales, Revenue, Price and Gross Margin of BioGaia
7.8 Bristol Myers Squibb
7.8.1 Company profile
7.8.2 Representative OTC Drug Product
7.8.3 OTC Drug Sales, Revenue, Price and Gross Margin of Bristol Myers Squibb
7.9 Bukwang Pharmaceutica
7.9.1 Company profile
7.9.2 Representative OTC Drug Product
7.9.3 OTC Drug Sales, Revenue, Price and Gross Margin of Bukwang Pharmaceutica
7.10 Chr. Hansen
7.10.1 Company profile
7.10.2 Representative OTC Drug Product
7.10.3 OTC Drug Sales, Revenue, Price and Gross Margin of Chr. Hansen
7.11 Cipla
7.11.1 Company profile
7.11.2 Representative OTC Drug Product
7.11.3 OTC Drug Sales, Revenue, Price and Gross Margin of Cipla
7.12 CoLucid
7.12.1 Company profile
7.12.2 Representative OTC Drug Product
7.12.3 OTC Drug Sales, Revenue, Price and Gross Margin of CoLucid
7.13 Daiichi Sankyo
7.13.1 Company profile
7.13.2 Representative OTC Drug Product
7.13.3 OTC Drug Sales, Revenue, Price and Gross Margin of Daiichi Sankyo
7.14 Friggs
7.14.1 Company profile
7.14.2 Representative OTC Drug Product
7.14.3 OTC Drug Sales, Revenue, Price and Gross Margin of Friggs
7.15 DSM
7.15.1 Company profile
7.15.2 Representative OTC Drug Product
7.15.3 OTC Drug Sales, Revenue, Price and Gross Margin of DSM
7.16 Eisai
7.17 Eli Lilly
7.18 Herbalife
7.19 Euradite
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF OTC DRUG
8.1 Industry Chain of OTC Drug
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF OTC DRUG
9.1 Cost Structure Analysis of OTC Drug
9.2 Raw Materials Cost Analysis of OTC Drug
9.3 Labor Cost Analysis of OTC Drug
9.4 Manufacturing Expenses Analysis of OTC Drug
CHAPTER 10 MARKETING STATUS ANALYSIS OF OTC DRUG
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of OTC Drug in This Report
1.2 Commercial Types of OTC Drug
1.2.1 Class A
1.2.2 Class B
1.3 Downstream Application of OTC Drug
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Household
1.4 Development History of OTC Drug
1.5 Market Status and Trend of OTC Drug 2013-2023
1.5.1 South America OTC Drug Market Status and Trend 2013-2023
1.5.2 Regional OTC Drug Market Status and Trend 2013-2023
CHAPTER 2 SOUTH AMERICA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of OTC Drug in South America 2013-2017
2.2 Consumption Market of OTC Drug in South America by Regions
2.2.1 Consumption Volume of OTC Drug in South America by Regions
2.2.2 Revenue of OTC Drug in South America by Regions
2.3 Market Analysis of OTC Drug in South America by Regions
2.3.1 Market Analysis of OTC Drug in Brazil 2013-2017
2.3.2 Market Analysis of OTC Drug in Argentina 2013-2017
2.3.3 Market Analysis of OTC Drug in Venezuela 2013-2017
2.3.4 Market Analysis of OTC Drug in Colombia 2013-2017
2.3.5 Market Analysis of OTC Drug in Others 2013-2017
2.4 Market Development Forecast of OTC Drug in South America 2018-2023
2.4.1 Market Development Forecast of OTC Drug in South America 2018-2023
2.4.2 Market Development Forecast of OTC Drug by Regions 2018-2023
CHAPTER 3 SOUTH AMERICA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole South America Market Status by Types
3.1.1 Consumption Volume of OTC Drug in South America by Types
3.1.2 Revenue of OTC Drug in South America by Types
3.2 South America Market Status by Types in Major Countries
3.2.1 Market Status by Types in Brazil
3.2.2 Market Status by Types in Argentina
3.2.3 Market Status by Types in Venezuela
3.2.4 Market Status by Types in Colombia
3.2.5 Market Status by Types in Others
3.3 Market Forecast of OTC Drug in South America by Types
CHAPTER 4 SOUTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of OTC Drug in South America by Downstream Industry
4.2 Demand Volume of OTC Drug by Downstream Industry in Major Countries
4.2.1 Demand Volume of OTC Drug by Downstream Industry in Brazil
4.2.2 Demand Volume of OTC Drug by Downstream Industry in Argentina
4.2.3 Demand Volume of OTC Drug by Downstream Industry in Venezuela
4.2.4 Demand Volume of OTC Drug by Downstream Industry in Colombia
4.2.5 Demand Volume of OTC Drug by Downstream Industry in Others
4.3 Market Forecast of OTC Drug in South America by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF OTC DRUG
5.1 South America Economy Situation and Trend Overview
5.2 OTC Drug Downstream Industry Situation and Trend Overview
CHAPTER 6 OTC DRUG MARKET COMPETITION STATUS BY MAJOR PLAYERS IN SOUTH AMERICA
6.1 Sales Volume of OTC Drug in South America by Major Players
6.2 Revenue of OTC Drug in South America by Major Players
6.3 Basic Information of OTC Drug by Major Players
6.3.1 Headquarters Location and Established Time of OTC Drug Major Players
6.3.2 Employees and Revenue Level of OTC Drug Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 OTC DRUG MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Bayer HealthCare
7.1.1 Company profile
7.1.2 Representative OTC Drug Product
7.1.3 OTC Drug Sales, Revenue, Price and Gross Margin of Bayer HealthCare
7.2 GlaxoSmithKline (GSK)
7.2.1 Company profile
7.2.2 Representative OTC Drug Product
7.2.3 OTC Drug Sales, Revenue, Price and Gross Margin of GlaxoSmithKline (GSK)
7.3 Johnson&Johnson
7.3.1 Company profile
7.3.2 Representative OTC Drug Product
7.3.3 OTC Drug Sales, Revenue, Price and Gross Margin of Johnson&Johnson
7.4 Pfizer
7.4.1 Company profile
7.4.2 Representative OTC Drug Product
7.4.3 OTC Drug Sales, Revenue, Price and Gross Margin of Pfizer
7.5 Sanofi
7.5.1 Company profile
7.5.2 Representative OTC Drug Product
7.5.3 OTC Drug Sales, Revenue, Price and Gross Margin of Sanofi
7.6 AstraZeneca
7.6.1 Company profile
7.6.2 Representative OTC Drug Product
7.6.3 OTC Drug Sales, Revenue, Price and Gross Margin of AstraZeneca
7.7 BioGaia
7.7.1 Company profile
7.7.2 Representative OTC Drug Product
7.7.3 OTC Drug Sales, Revenue, Price and Gross Margin of BioGaia
7.8 Bristol Myers Squibb
7.8.1 Company profile
7.8.2 Representative OTC Drug Product
7.8.3 OTC Drug Sales, Revenue, Price and Gross Margin of Bristol Myers Squibb
7.9 Bukwang Pharmaceutica
7.9.1 Company profile
7.9.2 Representative OTC Drug Product
7.9.3 OTC Drug Sales, Revenue, Price and Gross Margin of Bukwang Pharmaceutica
7.10 Chr. Hansen
7.10.1 Company profile
7.10.2 Representative OTC Drug Product
7.10.3 OTC Drug Sales, Revenue, Price and Gross Margin of Chr. Hansen
7.11 Cipla
7.11.1 Company profile
7.11.2 Representative OTC Drug Product
7.11.3 OTC Drug Sales, Revenue, Price and Gross Margin of Cipla
7.12 CoLucid
7.12.1 Company profile
7.12.2 Representative OTC Drug Product
7.12.3 OTC Drug Sales, Revenue, Price and Gross Margin of CoLucid
7.13 Daiichi Sankyo
7.13.1 Company profile
7.13.2 Representative OTC Drug Product
7.13.3 OTC Drug Sales, Revenue, Price and Gross Margin of Daiichi Sankyo
7.14 Friggs
7.14.1 Company profile
7.14.2 Representative OTC Drug Product
7.14.3 OTC Drug Sales, Revenue, Price and Gross Margin of Friggs
7.15 DSM
7.15.1 Company profile
7.15.2 Representative OTC Drug Product
7.15.3 OTC Drug Sales, Revenue, Price and Gross Margin of DSM
7.16 Eisai
7.17 Eli Lilly
7.18 Herbalife
7.19 Euradite
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF OTC DRUG
8.1 Industry Chain of OTC Drug
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF OTC DRUG
9.1 Cost Structure Analysis of OTC Drug
9.2 Raw Materials Cost Analysis of OTC Drug
9.3 Labor Cost Analysis of OTC Drug
9.4 Manufacturing Expenses Analysis of OTC Drug
CHAPTER 10 MARKETING STATUS ANALYSIS OF OTC DRUG
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
